| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |